MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

Conditions: Schizophrenia and Related Disorders; Mitochondrial Alteration; Cognitive Impairment Interventions: Drug: MitoQ; Drug: Placebo Sponsors: Mclean Hospital; Yale University; University of Lausanne Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials